GlassScriptPhysician profile
Gary R Bissonette
NPI 1114966538
$771.40
in general payments reported to CMS, 2019-2025
15 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.78 · 2022: $208 · 2023: $188 · 2024: $147 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $183.63 | 2021-2025 | Perclot, Preveleak, Floseal |
| Abbott Laboratories | $98.85 | 2021-2025 | Navitor, Jeti Peripheral Catheter, Esprit |
| Lemaitre Vascular, INC. | $95.27 | 2022-2023 | Artegraft Vascular Graft |
| Kerecis Limited | $84.81 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Atricure, INC. | $51.86 | 2022-2024 | |
| Medtronic, INC. | $42.78 | 2022-2023 | Penditure |
| Cook Medical LLC | $39.84 | 2022 | |
| Abiomed | $31.39 | 2024 | Impella |
| Aroa Biosurgery Incorporated | $27.79 | 2022 | |
| Amgen INC. | $23.42 | 2022 | |
| Cardiva Medical, INC. | $23.41 | 2025 | Cardiva Vascade 6/7f Vcs |
| Ethicon US, LLC | $23.31 | 2025 | Echelon Endopath |
| Cordis US Corp. | $18.01 | 2023 | Mynxgrip |
| Pfizer INC. | $14.43 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Bissonette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.